Ificipro

Ificipro

ciprofloxacin

Manufacturer:

Unique Pharma Lab

Distributor:

Unimed
Concise Prescribing Info
Contents
Ciprofloxacin HCl
Indications/Uses
Resp tract, middle ear, paranasal sinuses, kidneys &/or efferent urinary tract, genital organ, abdominal cavity, skin & soft tissue, eyes, bone & joint infections. Sepsis. Prophylaxis in patients w/ weakened immune system. Selective intestinal decontamination in immunosuppressed patients.
Dosage/Direction for Use
FC tab Resp tract infection & complicated UTI 250-500 mg bd. Acute, uncomplicated UTI 125 mg bd or 250 mg once-bd. Cystitis in premenopausal women & acute, uncomplicated gonorrhea 250 mg as single dose for 1 day. Extragenital gonorrhea 125 mg bd. Diarrhea 500 mg once-bd. Other infections 500 mg bd. Severe, life-threatening infections eg, Strep pneumonia, recurrent cystic fibrosis infection, bone & joint infections, septicemia, peritonitis (Pseudomonas, Staph or Strep is present) 750 mg bd. Renal impairment & continuous ambulatory peritoneal dialysis 500 mg once daily or 250 mg bd. CrCl 31-60 mL/min/1.73 m2 Max: 1,000 mg daily, 30-50 mL/min 250-500 mg every 12 hr, <30 mL/min/1.73 m2 Max: 500 mg daily, 5-29 mL/min 250-500 mg every 18 hr. Hemodialysis or peritoneal dialysis patient 250-500 mg every 24 hr (after dialysis). Infusion Resp tract infection 200-400 mg bd. Acute, uncomplicated UTI & extragenital gonorrhea 100 mg bd. Cystitis in premenopausal women & acute, uncomplicated gonorrhea 100 mg as single dose for 1 day. Complicated UTI, diarrhea & other infections 200 mg bd. Severe, life-threatening infections eg, Strep pneumonia, recurrent cystic fibrosis infections, bone & joint infections, septicemia, peritonitis (Pseudomonas, Staph, Strep is present) 400 mg tds. CrCl 31-60 mL/min/1.73 m2 Max: 800 mg IV daily, <30 mL/min/1.73 m2 Max: 400 mg IV daily. Duration: Kidney, urinary tract & abdominal cavity infections Up to 7 days. Patient w/ weakened body defenses Over the entire period of neutropenic phase. Osteomyelitis Max: 2 mth. All other infections 7-14 days. Strep infections At least 10 days. Chlamydia infection Min: 10 days.
Administration
May be taken with or without food: May be taken w/ meals to minimize GI discomfort. Do not take w/ antacids, Fe or dairy products.
Contraindications
Hypersensitivity to quinolones. Not recommended in childn <12 yr.
Special Precautions
Discontinue use if tendon pain occurs. Not to be used as 1st choice of drug for outpatients w/ pneumonia due to Pneumococcus. CNS disorder eg, severe cerebral arteriosclerosis or epilepsy. Avoid excessive urine alkalinization. Ensure adequate hydration. Concurrent use w/ dairy products or mineral fortified drinks eg, milk, yoghurt & Ca fortified orange juice. Renal impairment. Not to be used during pregnancy & lactation.
Adverse Reactions
Diarrhoea, vomiting, abdominal pain, headache, restlessness, rash.
Drug Interactions
Increased serum conc & elimination t½ of theophylline. Delayed excretion w/ probenecid.
MIMS Class
ATC Classification
J01MA02 - ciprofloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Presentation/Packing
Form
Ificipro infusion soln 200 mg/100 mL
Packing/Price
1's
Form
Ificipro FC tab 250 mg
Packing/Price
10 × 10's
Form
Ificipro FC tab 500 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in